Direxion Daily S&P Biotech Bull 3X ETF
LABU
51 hedge funds and large institutions have $27.3M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 22 closing their positions.
88% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 8
34% more capital invested
Capital invested by funds: $20.3M → $27.3M (+$6.99M)
0.04% more ownership
Funds ownership: 0.11% → 0.14% (+0.04%)
11% less funds holding
Funds holding: 57 → 51 (-6)
23% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 22
49% less call options, than puts
Call options by funds: $14.3M | Put options by funds: $28.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
+$1.97M |
| 2 |
Morgan Stanley
New York
|
+$1.65M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.3M |
| 4 |
Corient Private Wealth
Miami,
Florida
|
+$567K |
| 5 |
G
Gainplan
Bloomfield Hills,
Michigan
|
+$467K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$1.47M |
| 2 |
JF
Jump Financial
Chicago,
Illinois
|
-$1.05M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$366K |
| 4 |
Jane Street
New York
|
-$274K |
| 5 |
WEG
World Equity Group
Schaumburg,
Illinois
|
-$266K |
LABU Hedge Fund Activity: Q2 2023 in Review
51 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q2 2023, worth a combined $27.3M — up 34% from $20.3M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of LABU and 17 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 15 added.
The largest buyer was Squarepoint, adding an estimated $1.97M. The largest seller was Virtu Financial, exiting entirely with an estimated $1.47M sold.
- 51 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q2 2023, down from 57 in Q1 2023.
- Funds reported $27.3M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q2 2023, up 34% quarter-over-quarter.
- 17 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q2 2023 and 22 closed out, a net change of -5 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q2 2023 was Squarepoint, an estimated $1.97M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q2 2023 was Virtu Financial, an estimated $1.47M sold.
Based on aggregated 13F filings for Q2 2023.